Blinatumomab

(Mfr: AMG)(Conc: 0.125 and 0.375 mcg/mL^b)

Methylprednisolone sodium succinate

(Mfr: MYL)(Conc: 5 mg/mL^b)

Remarks:

Persistent particulate formation when blinatumomab is added to methylprednisolone; not observed when order of mixing was reversed

Ref:

³⁴⁰⁵,³⁴¹⁷